drugset / Trial / NCT00685464
Intravenous Versus Intracoronary Use of Abciximab
RandomizedFactorialOpen-labelTreatment
Summary
The aim of this study is to investigate wether intracoronary use of bolus Abciximab is superior to intravenous bolus in patients undergoing percutaneous coronary intervention.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abciximab | Monoclonal antibody | 0.125 ug/kg | Intravenous |